CG Oncology, Inc. - Common Stock (CGON)

Historical Holders from Q1 2024 to Q3 2025

Symbol
CGON on Nasdaq
CUSIP
156944100
Type / Class
Equity / Common Stock
Shares outstanding
76.6M
All holders as of September 30, 2025
Q3 2025
Total 13F shares, excl. options
77.6M
Holdings value
$3.13B
% of all portfolios
0.006%
Grand Portfolio weight change
+0%
Number of holders
175
Number of buys
87
Number of sells
-75
Average Value change %
+0%
Average buys %
+0.001%
Average sells %
-0.001%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of CG Oncology, Inc. - Common Stock (CGON)

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
VANGUARD GROUP INC 8.62% $265M 6.58M The Vanguard Group Sep 30, 2025
Decheng Capital Global Life Sciences Fund IV, L.P. 8.4% $99.3M 6.37M Xiangmin Cui Dec 31, 2024
WELLINGTON MANAGEMENT GROUP LLP 7.2% $222M 5.51M Wellington Management Group LLP Sep 30, 2025
Longitude Capital Partners IV, LLC 6% $121M 4.66M Patrick G. Enright Sep 11, 2025
Unique Diamond Investments Ltd 5.5% $65.7M 4.21M SONG, Hong Fang Dec 31, 2024
FMR LLC 5.1% $97M 3.86M FMR LLC Jun 30, 2025
TCG Crossover GP I, LLC 4.8% $57.2M 3.67M TCG Crossover GP I, LLC Mar 31, 2025
Seven Fleet Capital Management LP 2% $62.1M 1.54M Brian Liu Oct 6, 2025
Seven Fleet Partners LP 1.9% $39.3M 1.52M Seven Fleet Partners LP Sep 11, 2025

Institutional Holders of CG Oncology, Inc. - Common Stock (CGON)

Period Reported Shares, Excl. Options Value, Excl. Options Change Price Investors
2025 Q3 77.6M $3.13B +$92.1M $40.28 175
2025 Q2 75.9M $1.97B +$139M $26.00 161
2025 Q1 70.8M $1.74B +$98.3M $24.49 141
2024 Q4 66.1M $1.89B +$283M $28.68 137
2024 Q3 52.2M $1.96B +$277M $37.73 120
2024 Q2 43.3M $1.37B +$105M $31.57 110
2024 Q1 38.8M $1.7B +$1.66B $43.90 96